The World Health Organization (WHO) is considering launching a global platform trial by July to test three to four COVID-19 vaccines against placebo in partnership with several unnamed vaccine developers.

WHO hopes the trial would increase racial and ethnic diversity of study participants as well as a reduction in the number of people receiving a placebo in a single trial. The WHO trial would administer investigational vaccines to up to 80 percent of participants and placebo to only 20 percent.